Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Operating Income Loss of -$12.12 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +73.3% in Operating Income Loss from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: -$2.67 million | Q2 2011: -$6.90 million | Q3 2011: -$5.55 million | Q1 2012: -$8.19 million | Q2 2012: -$7.48 million | Q3 2012: -$5.37 million | Q1 2013: -$3.77 million | Q2 2013: -$4.81 million | Q3 2013: -$4.93 million | Q1 2014: -$4.11 million | Q2 2014: -$2.51 million | Q3 2014: -$11.06 million | Q1 2015: -$7.20 million | Q2 2015: -$7.15 million | Q3 2015: -$7.12 million | Q1 2016: -$11.28 million | Q2 2016: -$10.45 million | Q3 2016: -$11.68 million | Q1 2017: -$13.93 million | Q2 2017: -$13.57 million | Q3 2017: -$12.45 million | Q1 2018: -$16.67 million | Q2 2018: -$27.17 million | Q3 2018: -$22.58 million | Q1 2019: -$28.34 million | Q2 2019: -$19.70 million | Q3 2019: -$25.99 million | Q1 2020: -$27.69 million | Q2 2020: $6.58 million | Q3 2020: -$4.02 million | Q1 2021: -$27.26 million | Q2 2021: -$23.67 million | Q3 2021: -$18.88 million | Q1 2022: -$23.16 million | Q2 2022: -$24.57 million | Q3 2022: -$23.40 million | Q1 2023: -$19.56 million | Q2 2023: -$17.49 million | Q3 2023: -$15.05 million | Q1 2024: -$10.73 million | Q2 2024: -$12.20 million | Q3 2024: -$10.96 million | Q1 2025: -$9.94 million | Q2 2025: -$11.09 million | Q3 2025: -$10.88 million.
- Over the full 17 years of available data (2009 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Operating Income Loss has declined by 262.8%.
- Historical annual values: Fiscal year 2025: -$12.12 million | Fiscal year 2024: -$45.42 million | Fiscal year 2023: -$64.65 million | Fiscal year 2022: -$94.11 million | Fiscal year 2021: -$132.69 million | Fiscal year 2020: -$64.78 million | Fiscal year 2019: -$102.71 million | Fiscal year 2018: -$92.74 million | Fiscal year 2017: -$52.23 million | Fiscal year 2016: -$45.28 million | Fiscal year 2015: -$29.66 million | Fiscal year 2014: -$23.96 million | Fiscal year 2013: -$19.60 million | Fiscal year 2012: -$24.86 million | Fiscal year 2011: -$34.00 million | Fiscal year 2010: -$4.77 million | Fiscal year 2009: -$3.34 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: